Navigation Links
Gentris Corporation Launches New Pharmacogenomics Services
Date:7/12/2012

's Ion Torrent Personal Genome Machine (PGM) for next generation sequencing. The Ion Torrent PGM allows for rapid, deep sequencing of large areas of the genome, which can efficiently identify both common and rare variations that may better predict the safety and efficacy of new drugs in development. Currently, Gentris is using the Ion Torrent PGM for discovery initiatives with its pharmaceutical partners as well as part of a collaboration with UNC-Chapel Hill. 

Related Links: www.gentris.com

Quotes:

"The expansion of our services by using these platform technologies allows us to provide our clients quality and regulated services in all phases of the clinical development pipeline," said Dr. L.Scott Clark, Gentris Chief Scientific Officer. "It's very exciting to use the Ion Torrent for discovery initiatives, because the depth of coverage and resolution can reveal new SNPs and variations that may be clinically relevant. However, these results need to be verified on a second platform which Gentris can perform because of its extensive experience with real-time PCR, Sanger sequencing, and Sequenom platforms."  

"The key to successfully implementing pharmacogenomics is to use the right platform to answer your specific question," said Dr. Howard McLeod, Director of the UNC Institute for Pharmacogenomics and Individualized Therapy and Gentris Chief Scientific Advisor. "By integrating multiple platforms, Gentris has the ability to address the needs of pharmaceutical clients during any stage in the clinical development of a drug. I'm excited to be working with them to discover, translate, and validate new biomarkers that will have an impact on patient care."

About Gentris Corporation:

Founded in 2001, Gentris is located in Research Triangle Park, NC, where it provides pharmacogenomics and biorepository support for all phases of clinical studies and genomic biomarker progr
'/>"/>

SOURCE Gentris Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Gentris Corporation Partners with the Shanghai Institutes of Preventative Medicine
2. BioElectronics Corporation Announces Initiative for UK and German Markets
3. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
4. Luminex Corporation Announces Agreement to Acquire GenturaDx
5. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
6. BioElectronics Corporation Announces Indian Distributors Ecommerce Website
7. Celladon Corporation Receives Notice of Allowance from European Patent Office
8. FMC Corporation Acquires Phytone, Ltd., a Leading European Natural Colors Business
9. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
10. Centene Corporation Selected for Ohio Medicaid Contract
11. Premier healthcare alliance honors Atrium Medical Corporation for operational excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...   , First patient ... efficacy and safety of MSB0010718C in patients with metastatic Merkel ... aggressive skin cancer lacking effective treatments   MSB0010718C is ... clinical trial for the treatment of solid tumors that aims ... a subsidiary of Merck KGaA, Darmstadt, Germany ...
(Date:7/28/2014)... , July 28, 2014  Dignity Health St. ... received the Get With The Guidelines®-Stroke Silver-Plus Quality ... outlined by the American Heart Association/American Stroke Association ... the number four cause of death and a ... the United States , according to the ...
(Date:7/28/2014)... , July 28, 2014 STAAR Surgical ... manufacturer and marketer of implantable lenses and delivery systems ... second quarter results and conference call with investors to ... 30, 2014.  The Company rescheduled the release date and ... funeral services for Hideo Watanabe , President of ...
Breaking Medicine Technology:EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2
... K-V Pharmaceutical Company ( KVa; KVb) (the "Company") ... HOLX ) that site initiation and patient enrollment has ... in the ongoing trial of Gestiva™ (hydroxyprogesterone caproate injection, 250 ... of preterm birth in women pregnant with a single baby ...
... The Wireless-Life Sciences Alliance (WLSA) , which convenes innovators, globally relevant ... in wireless technologies, today hailed its partner organizations for their collaboration and ... , , ... , , ...
Cached Medicine Technology:K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 2K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 3K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 4K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 5K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 6K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 7K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 8K-V Pharmaceutical Announces Update on Confirmatory Trial of Gestiva(TM) 9Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 2Wireless-Life Sciences Alliance (WLSA) Applauds Partner Organizations for Supporting Goal of Improving Healthcare Via Wireless Technologies 3
(Date:7/29/2014)... 2014 This month, Therapy Changes ... to a Successful, Balanced Career.” The guide is geared ... seeking guidance on creating a successful career. , ... focus, determination, and understanding your strengths and limits,” says ... guide will uncover the elements to creating balance in ...
(Date:7/29/2014)... Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American ... access to essential pain medications for people living with ... the Pain initiative, this new partnership will help improve ... throughout the country. , Swaziland has the highest ... percent of adults ages 15-49 infected. Many of these ...
(Date:7/29/2014)... July 29, 2014 Representatives with BNatrl ... product called BNatrl Silver Solution 12ppm . , ... and spokesperson for BNatrl LLC. “It helps boost your ... from harmful pathogens and microbes.” , BNatrl develops and ... water products, with 10 percent of profits being used ...
(Date:7/29/2014)... TN (PRWEB) July 29, 2014 ... specializing in anesthesia, pain management and critical care, has ... “Ryan came to PhyMed in May 2013 as our ... an essential part of our organization and leadership team,” ... “Technological innovation is a cornerstone of our strategic vision ...
(Date:7/29/2014)... This Latest Guidebook for Conducting Pharma Clinical Trials ... only provided a comprehensive and thorough knowledge of the ... registration but also introduced the practical operation how to ... use the Chinese trial venues to keep drug development ... step. , The audiences of this guidebook are overseas ...
Breaking Medicine News(10 mins):Health News:Therapy Changes Releases New Guide to Building a Successful Career 2Health News:New partnership to improve access to essential pain medications for people living with HIV 2Health News:BNatrl Launches New Silver Solution Product 2Health News:PhyMed Names Dorr to Chief Information Office Post 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4
... Complex Rehab Market , , ... with 35 years of experience, has joined Alliance Seating ... complex rehab companies. O,Neill is an Assistive Technology Supplier ... and is responsible for sales and service of rehabilitation equipment ...
... 16 For the past 40 years, arc Thrift ... developmental,disabilities. This week, The Melvin and Elaine Wolf ... a Purpose" program. "As,one of the larger employers of ... partner with The Melvin and Elaine Wolf Foundation to ...
... a neurodegenerative disorder that causes the weakening of muscles, ... in 1 in 6,000 live births. While trans-splicing ... as a treatment for spinal muscular atrophy in cell-based ... the therapy to the human body. A University of ...
... The Journal of Nuclear Medicine SNM,s flagship publicationwill ... change to the publication allows the generous use of ... of research reports," said Heinrich R. Schelbert, M.D., editor ... . "Most important and critical, it strengthens the communication ...
... Mo. Evolving HIV viral strains and the adverse ... treatments propel scientists to continue exploring alternative HIV ... Missouri researcher has identified broad-spectrum aptamers. Aptamers are ... reproducing. In lab tests, aptamers known as RT5, ...
... autism are,struggling with a host of worries that impact ... their family will lack the life-long supports,needed to address ... released today by Easter Seals and made possible by ... Autism Study results reveal parents raising,children with autism are ...
Cached Medicine News:Health News:Veteran Rehab Specialist, Ted O'Neill, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania 2Health News:The Melvin and Elaine Wolf Foundation Donates $10,000 to arc Thrift Stores 2Health News:Journal of Nuclear Medicine premiers new, full-color design 2Health News:Researcher refining synthetic molecules to prevent HIV resistance 2Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 2Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 3Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 4Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 5Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 6
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: